Go Pro
→ 'Second Wave” Hitting Iran Soon? Wall Street Issues Warning (From TradeSmith) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Azenta, Inc. stock logo
AZTA
Azenta
$33.38
-1.6%		$26.65
$15.93
▼
$41.73
$1.46B1.37664,983 shs497,776 shs
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
$5.70
-1.4%		$6.08
$2.28
▼
$7.44
$1.48B0.632.08 million shs2.38 million shs
Personalis, Inc. stock logo
PSNL
Personalis
$14.04
-2.6%		$12.69
$4.44
▼
$16.39
$1.47B2.273.71 million shs1.04 million shs
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
$7.29
-1.2%		$5.43
$1.91
▼
$7.84
$390.85M0.64184,628 shs552,673 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Azenta, Inc. stock logo
AZTA
Azenta
0.00%+4.18%+24.65%+108.36%+4.05%
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
0.00%-8.51%-19.61%+37.35%+107.27%
Personalis, Inc. stock logo
PSNL
Personalis
0.00%-0.85%-9.88%+120.75%+190.68%
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
0.00%+12.85%+37.03%+107.69%+49.39%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Azenta, Inc. stock logo
AZTA
Azenta
$33.38
-1.6%		$26.65
$15.93
▼
$41.73
$1.46B1.37664,983 shs497,776 shs
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
$5.70
-1.4%		$6.08
$2.28
▼
$7.44
$1.48B0.632.08 million shs2.38 million shs
Personalis, Inc. stock logo
PSNL
Personalis
$14.04
-2.6%		$12.69
$4.44
▼
$16.39
$1.47B2.273.71 million shs1.04 million shs
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
$7.29
-1.2%		$5.43
$1.91
▼
$7.84
$390.85M0.64184,628 shs552,673 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Azenta, Inc. stock logo
AZTA
Azenta
0.00%+4.18%+24.65%+108.36%+4.05%
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
0.00%-8.51%-19.61%+37.35%+107.27%
Personalis, Inc. stock logo
PSNL
Personalis
0.00%-0.85%-9.88%+120.75%+190.68%
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
0.00%+12.85%+37.03%+107.69%+49.39%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Azenta, Inc. stock logo
AZTA
Azenta
2.43
Hold$41.2023.43% Upside
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
2.00
Hold$6.259.65% Upside
Personalis, Inc. stock logo
PSNL
Personalis
2.22
Hold$14.251.50% Upside
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
2.25
Hold$7.502.88% Upside

Current Analyst Ratings Breakdown

Latest TKNO, MRVI, PSNL, and AZTA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/11/2026
Azenta, Inc. stock logo
AZTA
Azenta
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/11/2026
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/11/2026
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeNeutral ➝ Buy$8.00
8/7/2026
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$5.50 ➝ $6.50
8/6/2026
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
8/5/2026
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
Roth Capital logo
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$7.00
8/5/2026
Azenta, Inc. stock logo
AZTA
Azenta
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$33.00 ➝ $37.00
8/5/2026
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
Roth Capital logo
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$7.00
7/21/2026
Personalis, Inc. stock logo
PSNL
Personalis
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
7/20/2026
Personalis, Inc. stock logo
PSNL
Personalis
Lake Street Capital logo
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold$16.25
7/20/2026
Personalis, Inc. stock logo
PSNL
Personalis
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$11.00 ➝ $16.25
(Data available from 8/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Azenta, Inc. stock logo
AZTA
Azenta
$613.81M2.38$1.81 per share18.42$34.47 per share0.97
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
$185.74M7.97$0.42 per share13.62$1.37 per share4.16
Personalis, Inc. stock logo
PSNL
Personalis
$69.65M21.11N/AN/A$2.25 per share6.24
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
$40.52M9.65N/AN/A$1.17 per share6.23
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Azenta, Inc. stock logo
AZTA
Azenta
-$55.76M-$2.76N/AN/AN/A-20.63%1.18%0.97%N/A
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
-$130.77M-$0.52N/AN/AN/A-37.07%-15.70%-8.17%N/A
Personalis, Inc. stock logo
PSNL
Personalis
-$81.27M-$1.09N/AN/AN/A-153.84%-46.47%-35.30%11/3/2026 (Estimated)
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
-$17.26M-$0.31N/AN/AN/A-38.37%-24.94%-16.53%N/A

Latest TKNO, MRVI, PSNL, and AZTA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
-$0.0435-$0.02+$0.0235-$0.08$48.67 million$51.44 million
8/5/2026Q2 2026
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
-$0.0843-$0.06+$0.0243-$0.06$10.95 million$12.19 million
8/4/2026Q3 2026
Azenta, Inc. stock logo
AZTA
Azenta
$0.1138$0.16+$0.0462$0.05$149.31 million$161.18 million
8/4/2026Q2 2026
Personalis, Inc. stock logo
PSNL
Personalis
-$0.2633-$0.30-$0.0367-$0.30$16.69 million$22.36 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Azenta, Inc. stock logo
AZTA
Azenta
$0.100.30%-100.00%N/A N/A
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
N/AN/AN/AN/AN/A
Personalis, Inc. stock logo
PSNL
Personalis
N/AN/AN/AN/AN/A
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Azenta, Inc. stock logo
AZTA
Azenta
N/A
2.50
2.21
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
0.49
4.05
4.96
Personalis, Inc. stock logo
PSNL
Personalis
N/A
5.28
5.08
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
0.21
4.49
3.48

Institutional Ownership

CompanyInstitutional Ownership
Azenta, Inc. stock logo
AZTA
Azenta
99.08%
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
50.25%
Personalis, Inc. stock logo
PSNL
Personalis
61.91%
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
13.81%

Insider Ownership

CompanyInsider Ownership
Azenta, Inc. stock logo
AZTA
Azenta
10.90%
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
2.49%
Personalis, Inc. stock logo
PSNL
Personalis
4.20%
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
13.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Azenta, Inc. stock logo
AZTA
Azenta
3,00043.81 million39.03 millionOptionable
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
610259.67 million253.21 millionOptionable
Personalis, Inc. stock logo
PSNL
Personalis
400104.72 million100.32 millionOptionable
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
24053.61 million46.54 millionNot Optionable

Recent News About These Companies

Wall Street Analysts Believe Alpha Teknova (TKNO) Could Rally 35.45%: Here's is How to Trade
August 10, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2971883/wall-street-analysts-believe-alpha-teknova-tkno-could-rally-35-45-here-s-is-how-to-trade?cid=cs-stocknewsapi-ft-fundamental_analysis|consensus_price_target-2971883
Alpha Teknova (NASDAQ:TKNO) Raised to Hold at Zacks Research
August 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/alpha-teknova-nasdaqtkno-raised-to-hold-at-zacks-research-2026-08-08/
Alpha Teknova (NASDAQ:TKNO) Research Coverage Started at Roth Capital
August 8, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30948195
Alpha Teknova (NASDAQ:TKNO) Upgraded to "Buy" at Wall Street Zen
August 8, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30947508
Alpha Teknova (NASDAQ:TKNO) Upgraded at Wall Street Zen
August 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/alpha-teknova-nasdaqtkno-upgraded-at-wall-street-zen-2026-08-08/
Alpha Teknova (TKNO) Stock Moves Higher on Booming Clinical Demand
August 7, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/blog/alpha-teknova-tkno-stock-moves-higher-on-booming-clinical-demand-1807999/
Teknova targets less than $8M 2026 free cash outflow as it lifts revenue guide to $45M-$47M
August 6, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4627100-teknova-targets-less-than-8m-2026-free-cash-outflow-as-it-lifts-revenue-guide-to-45m-47m
Roth Capital Upgrades Alpha Teknova (NASDAQ:TKNO) to Strong-Buy
August 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/roth-capital-upgrades-alpha-teknova-nasdaqtkno-to-strong-buy-2026-08-06/
Alpha Teknova Q2 Earnings Call Highlights
August 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/alpha-teknova-q2-earnings-call-highlights-2026-08-06/
Alpha Teknova (NASDAQ:TKNO) Issues Earnings Results, Beats Estimates By $0.02 EPS
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/alpha-teknova-nasdaqtkno-issues-earnings-results-beats-estimates-by-002-eps-2026-08-05/
Teknova Launches Build-Tek™, a Proprietary AI Reagent Assistant That Allows Customers to Configure Complex Custom Product Requests in Minutes
August 5, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/teknova-launches-build-tek-a-proprietary-ai-reagent-assistant-that-allows-customers-to-configure-complex-custom-product-requests-in-minutes-1036413072
Teknova Reports Second Quarter 2026 Financial Results
August 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/05/3339649/0/en/teknova-reports-second-quarter-2026-financial-results.html
Alpha Teknova (TKNO) to Release Quarterly Earnings on Wednesday
July 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/alpha-teknova-tkno-to-release-quarterly-earnings-on-wednesday-2026-07-29/
Teknova to Report Second Quarter 2026 Financial Results on August 5, 2026
July 22, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/22/3331688/0/en/teknova-to-report-second-quarter-2026-financial-results-on-august-5-2026.html
Alpha Teknova, Inc. $TKNO Holdings Boosted by Roubaix Capital LLC
July 19, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-alpha-teknova-inc-tkno-holdings-boosted-by-roubaix-capital-llc-2026-07-19/
Analysts Offer Insights on Healthcare Companies: Alpha Teknova (TKNO), Arcus Biosciences (RCUS) and Tenaya Therapeutics (TNYA)
June 4, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/2309178/analysts-offer-insights-on-healthcare-companies-alpha-teknova-tkno-arcus-biosciences-rcus-and-tenaya-therapeutics-tnya/
Analysts Offer Insights on Healthcare Companies: Alpha Teknova (TKNO) and REPRO-MED Systems (KRMD)
May 9, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TKNO/pressreleases/1763703/analysts-offer-insights-on-healthcare-companies-alpha-teknova-tkno-and-repro-med-systems-krmd/
Alpha Teknova, Inc. (NASDAQ:TKNO) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
May 9, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/alpha-teknova-inc-nasdaq-tkno-142331465.html
Alpha Teknova, Inc. (TKNO) Q1 2026 Earnings Call Transcript
May 8, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4901691-alpha-teknova-inc-tkno-q1-2026-earnings-call-transcript
Alpha Teknova Charts Cautious Path to 2027 Growth
May 7, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/alpha-teknova-charts-cautious-path-to-2027-growth?utm_source=marketbeat.com&utm_medium=referral
Alpha Teknova (TKNO) Q1 2026 Earnings Transcript
May 6, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/alpha-teknova-tkno-q1-2026-230740509.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Azenta stock logo

Azenta NASDAQ:AZTA

$33.38 -0.53 (-1.56%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$33.33 -0.05 (-0.15%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Maravai LifeSciences stock logo

Maravai LifeSciences NASDAQ:MRVI

$5.70 -0.08 (-1.38%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$5.65 -0.05 (-0.88%)
As of 08/14/2026 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as custom enzyme development and manufacturing and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody, and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California.

Personalis stock logo

Personalis NASDAQ:PSNL

$14.04 -0.38 (-2.64%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$14.30 +0.26 (+1.82%)
As of 08/14/2026 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Personalis, Inc. develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD) and recurrence in cancer; and ImmunoID NeXT, a tissue-based test that combines whole exome (DNA) and whole transcriptome (RNA) sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample. It also provides NeXT Personal Dx, a tumor-informed liquid biopsy test for detection of MRD and recurrence in cancer; and NeXT Dx, a comprehensive tumor profiling test that unlocks the entire exome (DNA) and transcriptome (RNA) with matched tumor-normal analysis. In addition, the company performs whole exome sequencing (WES) of cancer tissue and matched blood samples for diagnostic companies as an input to their products; and whole genome sequencing (WGS) on human samples for research projects, such as population sequencing initiatives, as well as offers sequencing and data analysis services to support population sequencing initiatives. Its customers include pharmaceutical companies, biopharmaceutical companies, diagnostics companies, universities, non-profits, government entities, and patients. The company was incorporated in 2011 and is headquartered in Fremont, California.

Alpha Teknova stock logo

Alpha Teknova NASDAQ:TKNO

$7.29 -0.09 (-1.22%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$7.35 +0.06 (+0.78%)
As of 08/14/2026 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas